NAT2 and carcinoma: The simultaneous measurements of both CMR and the NAT2 SNPs (reflecting both N- and O-acetylation) allowed for the assessment of the putative association between the O-acetylation status and bladder cancer, which provides insight on the potential biological mechanism of NAT2 genetic variants on bladder carcinogenesis.